Wealth Alliance LLC Decreases Holdings in Zoetis Inc. $ZTS

Wealth Alliance LLC lowered its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 8.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 12,475 shares of the company’s stock after selling 1,090 shares during the period. Wealth Alliance LLC’s holdings in Zoetis were worth $1,946,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in ZTS. Brighton Jones LLC increased its stake in Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after purchasing an additional 2,978 shares during the period. CWM LLC boosted its position in Zoetis by 23.7% during the 1st quarter. CWM LLC now owns 22,367 shares of the company’s stock valued at $3,683,000 after buying an additional 4,282 shares during the period. Florida Financial Advisors LLC increased its position in shares of Zoetis by 57.6% in the first quarter. Florida Financial Advisors LLC now owns 2,464 shares of the company’s stock valued at $406,000 after acquiring an additional 901 shares during the period. Signaturefd LLC raised its stake in shares of Zoetis by 6.9% during the first quarter. Signaturefd LLC now owns 9,613 shares of the company’s stock valued at $1,583,000 after acquiring an additional 618 shares during the last quarter. Finally, Whittier Trust Co. grew its stake in shares of Zoetis by 2.2% in the first quarter. Whittier Trust Co. now owns 12,437 shares of the company’s stock worth $2,048,000 after purchasing an additional 270 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on ZTS. UBS Group reduced their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Stifel Nicolaus set a $140.00 price target on shares of Zoetis in a research note on Tuesday, November 4th. JPMorgan Chase & Co. lowered their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, BTIG Research reduced their target price on Zoetis from $200.00 to $160.00 and set a “buy” rating on the stock in a report on Wednesday. Six equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.00.

Zoetis Price Performance

Shares of NYSE ZTS opened at $120.09 on Wednesday. The firm has a market cap of $52.92 billion, a P/E ratio of 20.67, a PEG ratio of 2.31 and a beta of 0.90. Zoetis Inc. has a twelve month low of $117.26 and a twelve month high of $181.85. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The company has a 50 day moving average of $142.82 and a 200 day moving average of $152.16.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.42 billion. During the same quarter last year, the company earned $1.58 EPS. The company’s quarterly revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. Zoetis’s payout ratio is currently 33.67%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.